235 results
Page 5 of 12
6-K
EX-1
ywalvvov0ru
28 May 19
Current report (foreign)
7:04am
6-K
EX-99
e5q4obchoixa sh5ju
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-99
5cb9wlo4ob0g2
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-99
wwvfdr 2fkjp
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-99
qxo3s qbfvyi5dnu
7 Feb 19
As Representative of the several Underwriters
12:00pm
424B5
o04jk
5 Feb 19
Prospectus supplement for primary offering
5:12pm
424B5
k01kg bdfclzxycqq28
4 Feb 19
Prospectus supplement for primary offering
5:52pm
F-3
jqa y0wu6w8bfd6eqc
26 Dec 18
Shelf registration (foreign)
4:11pm
F-3
EX-5.1
fjjy1y99rhjkyz0jx
26 Dec 18
Shelf registration (foreign)
4:11pm
F-3
EX-5.2
vmdda
26 Dec 18
Shelf registration (foreign)
4:11pm
6-K
EX-10.4
nfr4a1
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-10.3
nqmzzctxl3k2585d
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-99
un3zas1jw4zef0h2 yzf
13 Aug 18
BioLineRx Reports Second Quarter 2018 Financial Results
7:01am
6-K
EX-99
aq4b97q hcuc
22 May 18
BioLineRx Reports First Quarter 2018 Financial Results
7:00am
6-K
EX-99
cyc0s 2gv
17 May 18
BioLineRx Reports Results of Phase 2 Study
8:57am